NH - ナチュラル・ヘルス・トレンズ （NantHealth Inc.） ナチュラル・ヘルス・トレンズNHのチャート
NHの企業情報
| symbol | NH |
|---|---|
| 会社名 | Natural Health Trends Corp. （ナチュラル・ヘルス・トレンズ） |
| 分野（sector） | Technology ハイテク |
| 産業（industry） | EDP Services |
| 業種 | 先端医療機器_テクノロジ― 一般消費財（Consumer Products） |
| 概要 | 事業概要 ナントヘルス(NantHealth Inc.)はヘルスケアクラウドベースの情報技術（IT）企業である。同社は医療現場で実践的な健康情報を提供するために、単一の統合された臨床プラットフォームを通じて科学技術を統合する。同社はゲノムプロテオーム分光測定（GPS）がん検診を提供する。それは患者の腫瘍組織中に存在するタンパク質を、腫瘍および正常サンプルの全ゲノムおよびトランスクリプトーム配列決定と組み合わせて測定する分子検査と意思決定支援ソリューションである。また、ナント・オペレーティング・システム（NantOS）およびNantOSアプリケーションを、医療提供者と支払人、自営業の雇用者およびバイオ医薬品会社に提供する。同社はGPS Cancer、NantOS、NantOSアプリケーションを含む統合ソリューションであるCLINICSを提供する。CLINICSソリューションには、システム・インフラストラクチャ、ナレッジ・プラットフォーム、プロバイダ・プラットフォーム、およびPayorプラットフォームが含まれる。 ナチュラル・ヘルス・トレンズは米国の自然医薬品・化粧品販売会社。栄養補給商品やスキンケア製品などを提携ネットワ―クを通じて直接販売及び電子商取引で提供。主な商品は、「プレミアムノニジュ―ス」、「トリオティ―ン」、「クラスタ―X2」、「トリフュ―ジョン・マックス」、「アル―ラ」、「スキンダルジェンス」、「タイム・リストア」など。 NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. By offering efficient ways to move, interpret, and visualize complex and highly sensitive information, NantHealth helps its customers in healthcare, life sciences, logistics, telecommunications, and other industries, to automate, understand, and act on data while keeping it secure and scalable. |
| 本社所在地 | 609 Deep Valley Drive Suite 395 Rolling Hills Estates CA 90274 USA |
| 代表者氏名 | Patrick Soon-Shiong Patrick Soon-Shiong |
| 代表者役職名 | Chairman of the Board Chief Executive Officer Founder |
| 電話番号 | +1 310-853-7513 |
| 設立年月日 | 32478 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2016年 |
| 従業員数 | 149人 |
| url | www.naturalhealthtrendscorp.com |
| nasdaq_url | https://www.nasdaq.com/symbol/nh |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -39.55300 |
| 終値（lastsale） | 1.42 |
| 時価総額（marketcap） | 155449733.06 |
| 時価総額 | 時価総額（百万ドル） 153.26030 |
| 売上高 | 売上高（百万ドル） 88.36800 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 336.31330 |
| 当期純利益 | 当期純利益（百万ドル） -42.82700 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 NantHealth Inc revenues increased 4% to $44.3M. Net loss before extraordinary items decreased 49% to $43.8M. Revenues reflect Softwareas-a-service increase of 9% to $32.4M Sequencing and molecular analysis increase of 84% to $1.8M Home health care services increase of 17% to $3M. Lower net loss reflects Loss from related party equity method in decrease of 86% to $6.2M (expense). |
NHのテクニカル分析
NHのニュース
NantHealth’s Eviti Connect Achieves HITRUST Risk-based, 2-year Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance 2023/03/21 13:00:00 Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions transforming complex data into actionable insights, today announced its Eviti Connect solution has earned Certified status for information security by HITRUST. HITRUST Risk-based, 2-year (r2) Certified status demonstrates that NantHealth’s Eviti Connect solution has met key regulations and industry-defined requirements for managing risk. This achievement places NantHealth in an elite
Billionaire owner helps Morrisville firm NantHealth secure $22M financing 2023/03/09 01:42:21 Business Journals
(Triangle Business Journal)
NantHealth to receive $22.5M in new financing from Highbridge and Nant Capital 2023/03/06 14:20:36 Seeking Alpha
NantHealth (NH) entered into a credit agreement for a new senior secured term loan in principal amount of $22.5M.Net proceeds to be used for funding its existing businesses and for…
NantHealth Inc. (NH) produces promising results 2022/12/20 12:08:00 US Post News
As of Monday, NantHealth Inc.’s (NASDAQ:NH) stock closed at $4.21, down from $5.70 the previous day. While NantHealth Inc. has underperformed by -26.14%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NH fell by -72.75%, with highs and lows ranging from $17.25 to $1.57, whereas the […]
NantHealth Inc. (NASDAQ: NH) Shares Are Down -63.98% Year To Date. 2022/12/19 18:00:00 Marketing Sentinel
In the latest trading session, 0.61 million NantHealth Inc. (NASDAQ:NH) shares changed hands as the company’s beta touched 2.05. With the company’s most recent per share price at $4.14 changed hands at -$1.56 or -27.37% at last look, the market valuation stands at $22.12M. NH’s current price is a discount, trading about -316.67% off its … NantHealth Inc. (NASDAQ: NH) Shares Are Down -63.98% Year To Date. Read More »
NantHealth, Inc. (NH) Management on Q2 2022 Results - Earnings Call Transcript 2022/08/06 22:45:17 Seeking Alpha
NantHealth, Inc. (NASDAQ:NASDAQ:NH) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob…
NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript 2022/08/05 19:30:23 The Motley Fool
NH earnings call for the period ending June 30, 2022.
NantHealth GAAP EPS of -$0.11, revenue of $16.5M 2022/08/04 22:08:53 Seeking Alpha
NantHealth press release (NH): Q2 GAAP EPS of -$0.11.Revenue of $16.5M (+2.5% Y/Y).
NantHealth Reports 2022 Second Quarter Financial Results 2022/08/04 20:05:00 Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2022. “For the 2022 second quarter, we reported net revenue of $16.5 million, representing the third consecutive quarter of top-line growth,” said Ron Louks, Chief Operating Officer, NantHealth. “We are pleased to note that our overall gross mar
NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 2022/08/01 10:53:00 Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 second quarter on Thursday, August 4, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will be available to interested p
Head to Head Review: Marathon Digital (NASDAQ:MARA) & NantHealth (NASDAQ:NH) 2021/12/23 06:20:42 Transcript Daily
Marathon Digital (NASDAQ:MARA) and NantHealth (NASDAQ:NH) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, earnings, risk and institutional ownership. Volatility & Risk Marathon Digital has a beta of 4.73, meaning that its share price is […]
NantHealth (NASDAQ:NH) Issues Earnings Results, Misses Estimates By $0.02 EPS 2021/11/07 17:06:41 Dakota Financial News
NantHealth (NASDAQ:NH) announced its earnings results on Thursday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the Zacks consensus estimate of ($0.08) by ($0.02), MarketWatch Earnings reports. During the same quarter in the prior year, the company earned ($0.08) EPS. Shares of NH stock traded up $0.08 on Friday, reaching $1.77. []
NantHealth, Inc. Common Stock (NH) Q3 2021 Earnings Call Transcript 2021/11/05 18:31:51 The Motley Fool
NH earnings call for the period ending September 30, 2021.
NantHealth to Participate at the 2021 Jefferies London Healthcare Conference 2021/11/04 20:07:00 Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that the company will participate at the 2021 Jefferies London Healthcare Conference. Management plans to host virtual one-on-one and small group meetings with institutional investors on November 18 and 19, 2021. For additional information or to schedule a meeting with NantHealth management, please